ValiMed™ Medication Validation System And Related Information From Baxa Corporation Are Now Available At PublicRelationsNewsroom. com
The ValiMed Medication Validation System and related information are now available at PublicRelationsNewsroom. com. The ValiMed System, distributed by Baxa Corporation, offers clinicians a simple and cost-effective tool to ensure medication safety by verifying that medications are correctly compounded. Its patented technology validates compounded doses of high risk medications prior to dispensing.
Englewood, CO (PRWEB) June 15, 2007
The ValiMed Medication Validation System and related information are now available at http://publicrelationsnewsroom. com/_wsn/page19.html (http://publicrelationsnewsroom. com/_wsn/page19.html) for media and professional access. ValiMed, distributed by Baxa Corporation, uses enhanced photoemission spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics to provide an increased level of patient safety. ValiMed compares a medication's spectroscopic signature to the Medication Signature Library and returns an easy-to-understand "validated" or "not validated" result, requiring no user interpretation.
The expanded ValiMed System features patented technology that validates in seconds compounded doses of high-risk medications prior to dispensing. Verification of compounding accuracy is a requirement under USP 27-NF 22 Chapter 797, which regulates the compounding of sterile products. The ValiMed System can play a key role in demonstrating the safety of compounded sterile products (CSPs) under these requirements.
This expanded ValiMed System incorporates reports supporting compliance with USP 797 requirements. It also features a modified disposable, requiring a reduced (0.25 mL) sample volume for testing. "This next-generation ValiMed System addresses customer requests," notes Baxa Corporation Product Manager Mark Thrasher. "The addition of a quality assurance feature meets the regulatory requirements, while the smaller sample requirement more easily accommodates current pharmacy work flows."
Baxa, a long-time proponent of hospital pharmacy safety initiatives, recently launched its state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training. Products such as the ValiMed Medication Validation System can be demonstrated and evaluated there, as part of a technology overview for best practices. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements. The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www. baxa. com/starcenter (http://www. baxa. com/starcenter)
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www. baxa. com (http://www. baxa. com)
About CDEX, Inc.
CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to two distinct areas: (I) identification of substances of concern (e. g., explosives and illegal drugs for homeland security); and (II) validation of substances for anti-counterfeiting, brand protection and quality assurance (e. g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is a CDEX solution for the healthcare market. Corporate headquarters and research and development facilities for CDEX are located in Tucson, Arizona. For more information, visit http://www. cdex-inc. com (http://www. cdex-inc. com) and http://www. valimed. com (http://www. valimed. com) or contact CDEX, Inc. at 520.745.5172,
Contacts:
Baxa Corporation
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Http://www. baxa. com (http://www. baxa. com)
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
Http://www. absolutelypr. com (http://www. absolutelypr. com)
CDEX Inc.
Malcolm Philips or Stuart Poteet
520.745.5172
###
